ENFOGLOBE ACQUIRES AND PARTICIPATES IN INTERNATIONAL TECHNOLOGY DISTRIBUTION AND COMMERCIALIZATION. WE FORM STRATEGIC ALLIANCES IN THE USA AND IN EUROPE TO PROMOTE INNOVATION. SENSOR TECHNOLOGY PATENTED BY THE UNIVERSITY OF FLORIDA  IS ONE EXAMPLE.

Enfoglobe, Inc. is an early-stage diagnostic technology company providing software solutions for the medical industry including virtual reality simulators and remote patient health monitoring. The company will leverage a biosensors platform technology with potential for medical diagnostics that are inexpensive and allow remote and immediate analysis and care. With patented technology licensed from the University of Florida, the company is partnering with technology and medical institutions in Poland to build chips with biosensors and further develop a product that will improve medical care via remote diagnostics and telemedicine. The sensors have application in environmental and defense industries as well.

Technology

Enfoglobe’s diagnostic tool includes biosensor chips that analyze small amounts of a liquid, such as a patient’s blood, saliva, or breath condensate and generate instantaneous results without the use of expensive laboratories or the need for highly trained personnel. A large number of highly sensitive and affordable sensors, the size of tens of micrometers, are built onto a single chip to measure body fluids. By combining the diagnostic chips with an online platform, Enfoglobe’s aim is that patients in remote areas or their own homes can perform the diagnostic themselves and transfer the results safely via the internet to their doctor’s office for analysis. This platform also can be adapted for use in environmental and defense industries.

Business Model

Enfoglobe is partnering with a technology company and medical institutions in Poland to further develop the biosensors platform, to validate it using real body fluids, to create prototypes and to conduct clinical trials. After successful validation, Enfoglobe will start sales in Poland, and then market in Europe and the US.

Contact us for more information.